新冠疫情下如何组织开展高水平临床研究?

2020-07-22 郭亚兵, 孙剑, 朱宏 肝脏

新型冠状病毒肺炎疫情(以下简称“新冠疫情”)在武汉自报警发现到暴发过程,如同山洪来袭,初如涓涓溪流,继而骤然滔滔洪水,让人避之不及。2020年1月20日开始,武汉新冠定点医院发

新型冠状病毒肺炎疫情(以下简称“新冠疫情”)在武汉自报警发现到暴发过程,如同山洪来袭,初如涓涓溪流,继而骤然滔滔洪水,让人避之不及。2020年1月20日开始,武汉新冠定点医院发热门诊和病房出现“挤兑”险情,医务人员和医疗防护用品等医疗资源出现缺口,及时赶到湖北的全国各地医疗队和后勤支援,及时堵住了防疫溃口,解决了燃眉之急。但从长远来看,对于新发传染病的防控,最终的出路是要依靠科学研究。而作为临床一线的医务人员,开展高质量的临床研究更是责无旁贷。 2020年1月24日首批支援武汉的是广东和上海的高水平医院的医疗队伍,不论在医德、医疗水平、学术造诣等方面,都代表了国内的一流水平。能当排头尖兵,能打赢遭遇战,充分体现出了这支医疗队崇高的医德和医疗高水平的应变能力;尽管在抗疫后期进行了一些临床和实验研究[1],但在高水平临床研究上却乏善可陈。本文结合医疗队实际情况,就在疫情下如何开展临床研究进行经验总结。 一、初期舆论压力造成研究兴趣锐减 纵观国内情况,在疫情初期,病毒研究所和疾控中心等医学基础和应用研究人员做了卓有成效的基础工作[2],很快分离鉴定出了肺炎病原微生物——新型冠状病毒(后被正式

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=902651, encodeId=a80e90265128, content=很好的话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e21981035, createdName=gucan_cs, createdTime=Thu Nov 26 23:47:58 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803885, encodeId=51a680388561, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0692435677, createdName=13123c6d8dm, createdTime=Wed Jul 22 12:09:51 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028330, encodeId=782b1028330e5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 22 10:30:31 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803858, encodeId=cdb1803858da, content=冗长🌚, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Jul 22 10:07:26 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803842, encodeId=e89f803842e2, content=出发与临床,与大数据结合, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fae4968216, createdName=lcy5465, createdTime=Wed Jul 22 08:57:08 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803824, encodeId=21c3803824da, content=初涓涓细流, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Wed Jul 22 08:33:25 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803809, encodeId=70d2803809ae, content=<a href='/topic/show?id=3a3a22925b7' target=_blank style='color:#2F92EE;'>#临床研究#</a>写的一般, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22925, encryptionId=3a3a22925b7, topicName=临床研究)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Jul 22 07:58:01 CST 2020, time=2020-07-22, status=1, ipAttribution=)]
    2020-11-26 gucan_cs

    很好的话题

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=902651, encodeId=a80e90265128, content=很好的话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e21981035, createdName=gucan_cs, createdTime=Thu Nov 26 23:47:58 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803885, encodeId=51a680388561, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0692435677, createdName=13123c6d8dm, createdTime=Wed Jul 22 12:09:51 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028330, encodeId=782b1028330e5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 22 10:30:31 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803858, encodeId=cdb1803858da, content=冗长🌚, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Jul 22 10:07:26 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803842, encodeId=e89f803842e2, content=出发与临床,与大数据结合, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fae4968216, createdName=lcy5465, createdTime=Wed Jul 22 08:57:08 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803824, encodeId=21c3803824da, content=初涓涓细流, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Wed Jul 22 08:33:25 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803809, encodeId=70d2803809ae, content=<a href='/topic/show?id=3a3a22925b7' target=_blank style='color:#2F92EE;'>#临床研究#</a>写的一般, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22925, encryptionId=3a3a22925b7, topicName=临床研究)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Jul 22 07:58:01 CST 2020, time=2020-07-22, status=1, ipAttribution=)]
    2020-07-22 13123c6d8dm

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=902651, encodeId=a80e90265128, content=很好的话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e21981035, createdName=gucan_cs, createdTime=Thu Nov 26 23:47:58 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803885, encodeId=51a680388561, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0692435677, createdName=13123c6d8dm, createdTime=Wed Jul 22 12:09:51 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028330, encodeId=782b1028330e5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 22 10:30:31 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803858, encodeId=cdb1803858da, content=冗长🌚, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Jul 22 10:07:26 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803842, encodeId=e89f803842e2, content=出发与临床,与大数据结合, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fae4968216, createdName=lcy5465, createdTime=Wed Jul 22 08:57:08 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803824, encodeId=21c3803824da, content=初涓涓细流, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Wed Jul 22 08:33:25 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803809, encodeId=70d2803809ae, content=<a href='/topic/show?id=3a3a22925b7' target=_blank style='color:#2F92EE;'>#临床研究#</a>写的一般, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22925, encryptionId=3a3a22925b7, topicName=临床研究)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Jul 22 07:58:01 CST 2020, time=2020-07-22, status=1, ipAttribution=)]
    2020-07-22 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=902651, encodeId=a80e90265128, content=很好的话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e21981035, createdName=gucan_cs, createdTime=Thu Nov 26 23:47:58 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803885, encodeId=51a680388561, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0692435677, createdName=13123c6d8dm, createdTime=Wed Jul 22 12:09:51 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028330, encodeId=782b1028330e5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 22 10:30:31 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803858, encodeId=cdb1803858da, content=冗长🌚, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Jul 22 10:07:26 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803842, encodeId=e89f803842e2, content=出发与临床,与大数据结合, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fae4968216, createdName=lcy5465, createdTime=Wed Jul 22 08:57:08 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803824, encodeId=21c3803824da, content=初涓涓细流, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Wed Jul 22 08:33:25 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803809, encodeId=70d2803809ae, content=<a href='/topic/show?id=3a3a22925b7' target=_blank style='color:#2F92EE;'>#临床研究#</a>写的一般, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22925, encryptionId=3a3a22925b7, topicName=临床研究)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Jul 22 07:58:01 CST 2020, time=2020-07-22, status=1, ipAttribution=)]
    2020-07-22 神盾医疗局局长Jack

    冗长🌚

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=902651, encodeId=a80e90265128, content=很好的话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e21981035, createdName=gucan_cs, createdTime=Thu Nov 26 23:47:58 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803885, encodeId=51a680388561, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0692435677, createdName=13123c6d8dm, createdTime=Wed Jul 22 12:09:51 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028330, encodeId=782b1028330e5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 22 10:30:31 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803858, encodeId=cdb1803858da, content=冗长🌚, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Jul 22 10:07:26 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803842, encodeId=e89f803842e2, content=出发与临床,与大数据结合, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fae4968216, createdName=lcy5465, createdTime=Wed Jul 22 08:57:08 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803824, encodeId=21c3803824da, content=初涓涓细流, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Wed Jul 22 08:33:25 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803809, encodeId=70d2803809ae, content=<a href='/topic/show?id=3a3a22925b7' target=_blank style='color:#2F92EE;'>#临床研究#</a>写的一般, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22925, encryptionId=3a3a22925b7, topicName=临床研究)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Jul 22 07:58:01 CST 2020, time=2020-07-22, status=1, ipAttribution=)]
    2020-07-22 lcy5465

    出发与临床,与大数据结合

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=902651, encodeId=a80e90265128, content=很好的话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e21981035, createdName=gucan_cs, createdTime=Thu Nov 26 23:47:58 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803885, encodeId=51a680388561, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0692435677, createdName=13123c6d8dm, createdTime=Wed Jul 22 12:09:51 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028330, encodeId=782b1028330e5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 22 10:30:31 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803858, encodeId=cdb1803858da, content=冗长🌚, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Jul 22 10:07:26 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803842, encodeId=e89f803842e2, content=出发与临床,与大数据结合, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fae4968216, createdName=lcy5465, createdTime=Wed Jul 22 08:57:08 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803824, encodeId=21c3803824da, content=初涓涓细流, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Wed Jul 22 08:33:25 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803809, encodeId=70d2803809ae, content=<a href='/topic/show?id=3a3a22925b7' target=_blank style='color:#2F92EE;'>#临床研究#</a>写的一般, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22925, encryptionId=3a3a22925b7, topicName=临床研究)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Jul 22 07:58:01 CST 2020, time=2020-07-22, status=1, ipAttribution=)]
    2020-07-22 老婆子

    初涓涓细流

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=902651, encodeId=a80e90265128, content=很好的话题, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=21e21981035, createdName=gucan_cs, createdTime=Thu Nov 26 23:47:58 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803885, encodeId=51a680388561, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0692435677, createdName=13123c6d8dm, createdTime=Wed Jul 22 12:09:51 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028330, encodeId=782b1028330e5, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jul 22 10:30:31 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803858, encodeId=cdb1803858da, content=冗长🌚, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Jul 22 10:07:26 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803842, encodeId=e89f803842e2, content=出发与临床,与大数据结合, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3fae4968216, createdName=lcy5465, createdTime=Wed Jul 22 08:57:08 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803824, encodeId=21c3803824da, content=初涓涓细流, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200720/956eb01f4b594ee783debae7a44d9096/e569cb8381764328b493c23491d86c27.jpg, createdBy=2cbc5401622, createdName=老婆子, createdTime=Wed Jul 22 08:33:25 CST 2020, time=2020-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=803809, encodeId=70d2803809ae, content=<a href='/topic/show?id=3a3a22925b7' target=_blank style='color:#2F92EE;'>#临床研究#</a>写的一般, beContent=null, objectType=article, channel=null, level=null, likeNumber=200, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22925, encryptionId=3a3a22925b7, topicName=临床研究)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Jul 22 07:58:01 CST 2020, time=2020-07-22, status=1, ipAttribution=)]
    2020-07-22 lovetcm

    #临床研究#写的一般

    0

相关资讯

疫情防控丨阜外医院:做好常态化疫情防控 为心血管疾病患者提供优质医疗服务

在7月10日下午举行的北京市新冠肺炎疫情防控工作新闻发布会上,中国医学科学院阜外医院副院长杨伟宪介绍了疫情期间阜外医院的防控工作情况。

Acta Neuropathologica:一例COVID-19的青年人H3K27M突变型弥漫性脑胶质瘤伴随广泛的瘤内微血栓

2019年新型冠状病毒病(COVID-19)的出现给肿瘤患者带来了独特的挑战。除了对获得治疗的影响外,初步研究表明癌症患者感染和死亡的风险增加。

住院4个月,这名患者终于回家!外媒:越南成功抗疫象征

近日,越南第91例新冠确诊病例出院,引发外界关注。这名越南国家航空公司的英国籍飞行员住院近四个月,曾一度病重,在越南医务人员不分昼夜的照顾下,如今终于痊愈回家。外媒评论称,这是越南“成功抗

新冠肺炎疫情防控常态化下,实验室生物安全监管要做到这四点!

目前新冠肺炎疫情防控已进入常态化,为进一步加强常态化下的实验室生物安全监管,国家卫生健康委印发了《国家卫生健康委办公厅关于在新冠肺炎疫情常态化防控中的实验室生物安全监督管理的通知》(以下简称《通知》)

防疫常态化,医疗机构诊疗流程规范出炉!

为进一步落实常态化疫情防控工作有关要求,规范医疗机构诊疗流程,保障群众医疗服务需求,7月13日,国务院应对新冠肺炎疫情联防联控机制医疗救治组发布了《关于疫情常态化防控下规范医疗机构诊疗流程的通知》。

战疫启示录:张抒扬:将协和经验移植到武汉

当张抒扬书记带领北京协和医院第二批援鄂医疗队2月7日到达武汉时,正是武汉疫情发展的“至暗”时刻,每天确诊人数过千,有时甚至两三千人,大批重症病人涌向医院。看着这么多重症病人等着